STTCOMP BOT, TA LONG
Botanix Pharmaceuticals
MC $85m
Cash $15m
Botanix develops therapeutics for treatment of skin diseases.
It uses a proprietary drug delivery system (Permetrex) for direct skin delivery of pharmaceuticals, and has a pipeline of Permetrex enabled products.
In Q2 BOT will commence Phase 2 Acne Trials, and receive results for Phase 1B Dermatitis trials.
Minervini tip number 2 (TGN, BOT)
Last 3 months has seen the construction of Base 2, which saw declining volumes throughout.
Retracements throughout Base 2 reduced from 25% to 14%.
Not really any shakeouts throughout the building of the base however.
Breakout on volume today. Buy price 14 cents. Stop loss 13 cents.
Don't think I've ever cheered for a BOT before.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 30 Apr
STTCOMP BOT, TA LONG Botanix Pharmaceuticals MC $85m Cash $15m...
-
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XAO (ASX) to my watchlist
(20min delay)
|
|||||
Last
8,471.3 |
Change
-67.100(0.79%) |
Mkt cap ! n/a |
Open | High | Low |
8,538.4 | 8,538.4 | 8,469.6 |
Featured News
XAO (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online